Integrated BioPharma Inc. (OTCMKTS:INBP) Sees Significant Increase in Short Interest

Integrated BioPharma Inc. (OTCMKTS:INBP) saw a significant increase in short interest in October. As of October 15th, there was short interest totaling 509 shares, an increase of 12,625.0% from the September 30th total of 4 shares. Currently, 0.0% of the shares of the stock are sold short. Based on an average daily trading volume, of 30,205 shares, the short-interest ratio is currently 0.0 days.

Integrated BioPharma Price Performance

Shares of INBP opened at $0.17 on Tuesday. Integrated BioPharma has a one year low of $0.14 and a one year high of $0.42. The business’s 50 day simple moving average is $0.18 and its 200-day simple moving average is $0.23.

Integrated BioPharma (OTCMKTS:INBP) last released its quarterly earnings results on Friday, September 25th. The company reported ($0.04) EPS for the quarter. Integrated BioPharma had a negative return on equity of 14.78% and a negative net margin of 6.48%. The business had revenue of $9.80 million for the quarter.

About Integrated BioPharma

Integrated BioPharma, Inc (OTCMKTS:INBP) is a healthcare products company engaged in the manufacture and distribution of vitamins, nutritional supplements, herbal products, and pharmaceutical products. Its activities are focused on products intended to support general health and wellness.

The company has historically served the U.S. market through a combination of proprietary products, contract manufacturing, and wholesale distribution activities. Its manufacturing capabilities have included a range of product formats, such as capsules, tablets, softgels, liquids, powders, creams, and lotions, depending on customer and product requirements.

Integrated BioPharma’s operations have included the development, production, and distribution of health-related consumer products for its own brands and other businesses.